WELL Health Technologies Corp. is pursuing a listing on the TSX Venture Exchange for its subsidiary, WELLSTAR Technologies [1].
This move signals a strategic shift to separate the AI-driven software platform from the parent company to accelerate growth and attract specialized capital. By becoming a publicly traded entity, WELLSTAR can leverage its own equity to scale its healthcare software operations across Canada.
The proposal includes a concurrent financing round of approximately $50 million [1], [2]. This funding is supported by a Canadian bank-owned asset manager [1]. The listing is intended to facilitate further growth for the platform, which is described as one of Canada's leading healthcare software and AI platforms [1], the company said.
Reports indicate that the listing may be achieved by way of a reverse takeover [4]. A reverse takeover is a common mechanism for private companies to gain public status quickly by merging with an existing shell company listed on an exchange.
"WELLSTAR is expected to become a publicly listed company through a TSXV listing, supported by a Concurrent Financing..." said the Financial Post [1].
The financing is expected to close soon, following the completion of the planned TSXV listing process [1], [2]. The company has not specified the exact date for the commencement of trading, though the process is currently underway.
"WELL Health Technologies Corp. controlled WELLSTAR Technologies to list on TSX-V by way of RTO and undertake $50M brokered..." said the Private Capital Journal [4].
“WELLSTAR is expected to become a publicly listed company through a TSXV listing”
The spin-off of WELLSTAR allows WELL Health to unlock the specific valuation of its AI and software assets, which often trade at higher multiples than traditional healthcare services. By securing $50 million in fresh capital and a public listing, the subsidiary can pursue aggressive expansion and product development without relying solely on the parent company's balance sheet.
